ConveloTx is a company headquartered in the United States.
ConveloTx develops patented remyelination-enhancing therapies targeting the central nervous system to promote repair and regeneration for multiple sclerosis patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.